» Articles » PMID: 7736570

Degradation of MRNA in Eukaryotes

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1995 Apr 21
PMID 7736570
Citations 228
Authors
Affiliations
Soon will be listed here.
Abstract

Based on the above mechanisms of mRNA degradation, an integrated model of mRNA turnover can be proposed (Figure 1). In this model, all polyadenylated mRNAs would be degraded by the deadenylation-dependent pathway at some rate. In addition to this default pathway, another layer of complexity would come from degradation mechanisms specific to individual mRNAs or to classes of mRNAs. Such mRNA-specific mechanisms would include sequence-specific endonuclease cleavage and deadenylation-independent decapping. Thus, the overall decay rate of an individual transcript will be a function of its susceptibility to these turnover pathways. In addition, cis-acting sequences that specify mRNA decay rate, as well as regulatory inputs that control mRNA turnover, are likely to affect all the steps of these decay pathways. One important goal in future work will be to identify the gene products that are responsible for the nucleolytic events in these pathways and to delineate how specific mRNA features act to affect the function of these degradative activities. The identification of distinct mRNA decay pathways should allow, genetic and biochemical approaches that can be designed to identify these gene products. A second important goal is to understand the nature of the interaction between the 5' and 3' termini, which may also be critical for efficient translation.

Citing Articles

The ribosome as a platform to coordinate mRNA decay.

Muller M, Becker T, Denk T, Hashimoto S, Inada T, Beckmann R Nucleic Acids Res. 2025; 53(4).

PMID: 39921564 PMC: 11806357. DOI: 10.1093/nar/gkaf049.


Non-redundant roles for the human mRNA decapping cofactor paralogs DCP1a and DCP1b.

Vukovic I, Barnada S, Ruffin J, Karlin J, Lokareddy R, Cingolani G Life Sci Alliance. 2024; 7(11).

PMID: 39256052 PMC: 11387620. DOI: 10.26508/lsa.202402938.


Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects.

Hegde M, Sandbhor P, J A, Gota V, Goda J Front Oncol. 2023; 13:1168454.

PMID: 37483515 PMC: 10357293. DOI: 10.3389/fonc.2023.1168454.


Quantifying Information of Dynamical Biochemical Reaction Networks.

Jiang Z, Su Y, Yin H Entropy (Basel). 2023; 25(6).

PMID: 37372231 PMC: 10297245. DOI: 10.3390/e25060887.


SPT5 affects the rate of mRNA degradation and physically interacts with CCR4 but does not control mRNA deadenylation.

Cui Y, Chiang Y, Viswanathan P, Lee D, Denis C Am J Mol Biol. 2023; 2(1):11-20.

PMID: 36910576 PMC: 9997522. DOI: 10.4236/ajmb.2012.21002.